Our governance

The main decision-making, executive and managerial bodies at Medicines and Healthcare products Regulatory Agency.

Corporate governance

We’re governed by a board, which is advised by the corporate executive team (CET).

The Board

The Board is responsible for advising on the strategic development of the agency and ensuring that targets set out in the business plan and agreed with ministers are met.

The Board doesn’t have any involvement in any regulatory decisions affecting medicines or medical devices. These are the responsibility of the chief executive, working through the corporate executive team, and of the expert advisory committees.

MHRA Board meeting: 12 February 2016

You can download papers from the 12 February 2016 Board Meeting in our filecamp folder.

Corporate executive team

The corporate executive team (CET) - previously the executive board - is the highest executive decision-making body of the agency. The CET is chaired by the chief executive, Dr Ian Hudson, and is made up of:

the directors of each of MHRA’s divisions

the director of the National Institute for Biological Standards and Control

Conflicts of interest between our 3 constituent groups

The work carried out by MHRA, the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD) is closely linked. Since our merger we know that some of the work NIBSC and CPRD do may need to be regulated by MHRA. We know that this is a potential conflict of interest because of our close relationship. To help deal with these situations, we have produced a: